-+ 0.00%
-+ 0.00%
-+ 0.00%

ARMATA PHARMACEUTICALS RECEIVES U.S. FDA BREAKTHROUGH THERAPY DESIGNATION FOR AP-SA02

路透·09/14/2026 11:00:02

登录查看新闻详情